Story Navigation
-
From Our LabsBiomedical ResearchDrug DiscoveryNovartis Institutes for BioMedical ResearchReimagine MedicineNew Scientific DiscoveriesJul 19, 2021Molecular glue kills cancer cells in mice
Compounds block a protein involved in many cancers by cementing it shut.
From Our Labs -
From Our LabsBiomedical ResearchDigitalDrug DiscoveryNovartis Institutes for BioMedical ResearchPostdoc ProgramDrug DesignJul 20, 2021Tuning drugs to succeed on the cell’s surface
Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.
From Our Labs -
From Our LabsBiomedical ResearchNovartis Institutes for BioMedical ResearchPostdoc ProgramScientific DiscoveriesJul 19, 2021Building brain organoids to shed light on disease
Three-dimensional clusters of human neurons could allow scientists to watch neurological diseases develop in the lab.
From Our Labs -
From Our LabsBiomedical ResearchMedical InnovationsNovartis Institutes for BioMedical ResearchPostdoc ProgramJul 19, 2021With a "brain in a dish," researchers take on neurological disorders
Neurological diseases develop out of sight. Novartis neuroscientists are bringing them into the light, using human brain cells grown in the lab.
From Our Labs -
From Our LabsBiomedical ResearchGene SequencingNovartis Institutes for BioMedical ResearchReimagine MedicineNext Generation SequencingGenetic DiseaseJul 19, 2021Electrical brainstorms traced to genetic mutations
Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.
From Our Labs -
From Our LabsNovartis Institutes for BioMedical ResearchNew Scientific DiscoveriesScientific ResearchGenetic DiseaseJul 19, 2021Eye disease tracked to a glitch in starburst cells
A cellular computing error wreaks havoc on vision.
From Our Labs -
From Our LabsBiomedical ResearchDrug DiscoveryNovartis Institutes for BioMedical ResearchReimagine MedicineNew Scientific DiscoveriesScientific ResearchJul 19, 2021Hooked on science, Jay Bradner becomes top researcher at Novartis
New NIBR President Jay Bradner shares on drug discovery, his leadership style and what’s next for his career in biomedical research.
From Our Labs -
From Our LabsBiomedical ResearchDrug DiscoveryNeuroscienceNovartis Institutes for BioMedical ResearchPostdoc ProgramGenetic DiseaseJul 20, 2021When tiny brains are best for brain research
Zebrafish imaging sheds light on human neurological conditions.
From Our Labs -
From Our LabsDrug DiscoveryNovartis Institutes for BioMedical ResearchPostdoc ProgramScientific ResearchCareersClinical TrialsJul 19, 20215 tips for making smart decisions on research projects
Make smart decisions about your research projects.
From Our Labs -
From Our LabsNovartis Institutes for BioMedical ResearchReimagine MedicineCancer Research InstituteJul 19, 2021CRISPR genome editing fuels cancer drug discovery
Genome editing advances drug discovery in biomedical research.
From Our Labs -
From Our LabsDrug DiscoveryGene SequencingNovartis Institutes for BioMedical ResearchClinical ResearchBiomedical JobsDrug DesignJul 20, 2021Rediscovering the power of nature’s exquisite complexity
Read how nature's medicine chest empowers our drug discovery chemists to advance biomedical research
From Our Labs -
From Our LabsDrug DiscoveryNovartis Institutes for BioMedical ResearchTropical DiseasesClinical ResearchBiomedical JobsEye DisordersJul 20, 2021Opening chemistry education to the world
Novartis taps MOOC technology to share chemistry education with the world
From Our Labs